Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Rahman, Alvi
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
Association between gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease
Location:Argyle 2
Alvi Rahman
Raman, Sudha
Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
Using Pharmacoepidemiology Database Resources to Address Drug Safety Research
Location:Argyle 3
Sudha Raman
Intermediate Pharmacoepidemiology: Approaches to Unmeasured Confounder
Location:Argyle 1
Sudha Raman
Ramcharran, Darmendra
GSK
Person-generated Health Data: Is Pharmacoepidemiology Ready for this New Frontier?
Location:Argyle 3
Darmendra Ramcharran
Rasmussen, Lotte
Syddansk Universitet
Introduction to Drug Utilization Research: The Conduct of Real-World Drug Utilization Studies: Describe and Compare
Location:MR106/107
Lotte Rasmussen
Advanced Drug Utilization Research: The Conduct of Real-World Drug Utilization Studies: Development And Evaluation of Interventions to Improve the Quality of Medication Use
Location:MR106/107
Lotte Rasmussen
Data to Action: Leveraging Drug Utilization Research to Shift Clinical Practice and Health Policy
Location:Argyle 2
Lotte Rasmussen
Rasouliyan, Lawrence
OMNY Health
Lightning Session 1
Location:Argyle 3
Lawrence Rasouliyan
Rassen, Jeremy
Aetion
What Can Be Learned From Machines
Location:MR202
Jeremy Rassen
Propensity Scores in Pharmacoepidemiology
Location:Argyle 2
Jeremy Rassen
Applied Sensitivity Analyses in Pharmacoepidemiology Database Studies
Location:Argyle 2
Jeremy Rassen
Privacy-Preserving Solutions for Real-World Data (RWD) Access and Collaboration: Challenges & Opportunities
Location:MR201
Jeremy Rassen
Rathnayaka, Nuvan
TargetRWE
Orthogonalized regression for causal inference: a pharmacoepidemiologist’s dream?
Location:Argyle 2
Nuvan Rathnayaka
Regan, Annette
University of San Francisco, San Francisco CA, USA
Intermediate /Advanced Topics in Vaccine Safety and Effectiveness
Location:MR202
Annette Regan
Rentsch, Christopher
London School of Hygiene & Tropical Medicine
Lightning Session 1
Location:Argyle 3
Christopher Rentsch
Reynolds, Matthew
Flatiron Health
Using Pharmacoepidemiology Database Resources to Address Drug Safety Research
Location:Argyle 3
Matthew Reynolds
Rijnbeek, Peter
Department of Medical Informatics, Erasmus University Medical Center
Scaling-up Real-World Evidence Generation for Regulators in Europe: DARWIN EU
Location:MR202
Peter Rijnbeek
Rios, Paula
EPI-PHARE
Early-life cancer risk among children conceived by assisted reproductive technology: A comparative nationwide cohort study from the French National Mother-Child Register "EPI-MERES"
Location:MR202
Paula Rios
Ritchey, Mary Beth
Food and Drug Administration
Lightning Session 2
Location:Argyle 1
Mary Beth Ritchey
Pharmacoepidemiologist's Toolbox for Professional Empowerment
Location:Argyle 1
Mary Beth Ritchey
Medical Device Epidemiology
Location:MR605
Mary Beth Ritchey
Person-generated Health Data: Is Pharmacoepidemiology Ready for this New Frontier?
Location:Argyle 3
Mary Beth Ritchey
Rivera, Donna
Oncology Center of Excellence, US Food and Drug Administration
The "Sea" of Cancer
Location:MR109
Donna Rivera
Town Hall: Global Regulatory Forum on Real-World Evidence; Sponsored by ISPE's RWE Collaborative SIG
Location:Ballroom
Donna Rivera
Cancer Pharmacoepidemiology and Genomics: What You Should Know in the Era of Precision Medicine
Location:MR501/502
Donna Rivera
Translating Real-World Evidence and Other Pharmacoepidemiological Research Findings into Policy and Clinical Practice: How Well are We Doing and What are the Opportunities for Improvement?
Location:MR202
Donna Rivera
Rivero-Ferrer, Elena
RTI Health Solutions
Don't Lose Heart
Location:Argyle 3
Elena Rivero-Ferrer
Rothnie, Kieran
GSK
Bias Introduced by COVID-19 Related Healthcare Disruptions in Safety and Effectiveness Studies: Proposing Methodological Solutions
Location:Argyle 1
Kieran Rothnie
Rough, Kathryn
IQVIA
Introduction to Machine Learning for Pharmacoepidemiologists
Location:Argyle 3
Kathryn Rough
Deep Learning for Pharmacoepidemiologists: An Accessible Introduction to Neural Networks
Location:Argyle 2
Kathryn Rough
Roy, Debabrata
Drug Safety Research Unit
COVID Consequences
Location:MR202
Debabrata Roy
Roy, Jason
Rutgers University School of Public Health
Ready or Not, Here Come Estimands! The Emerging Attention to Causal Estimands in Real-World Evidence Studies
Location:MR202
Jason Roy
Russo, Leo
Pfizer
Lightning Session 2
Location:Argyle 1
Leo Russo
Ryan, Patrick
Johnson & Johnson
Scaling-up Real-World Evidence Generation for Regulators in Europe: DARWIN EU
Location:MR202
Patrick Ryan
